IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?

J. B. Greer currently holds a grant with Abbvie. I. Oikonomou has past research grants with Janssen Pharmaceutica, Pfizer, and Celgene. C. A. Siegel currently consults for Janssen Pharmaceutica, Abbvie, and UCB, and has ongoing research grants with Janssen Pharmaceutica, Abbvie, and UCB. R. K. Cross consults, participates in advisory boards, and has research grant support with Abbvie and Janssen Pharmaceutica; Dr. Cross also participates in Takeda's advisory board. A. Tinsley has previously consulted for Janssen Pharmaceutica and is involved in ongoing consulting and lecturing for Abbvie. D. G. Binion has an ongoing grant with Janssen Pharmaceutica and has previously consulted for Abbvie, Janssen Pharmaceutica, Cubist Pharmaceuticals, Salix Pharmaceuticals, and Takeda. M. D. Regueiro has previously consulted for UCB, Takeda, Shire Plc, Abbvie, and Janssen Pharmaceutica.